V16.F Virbac SA

Healthcare Pharmaceuticals Frankfurt Exchange
351.00 EUR
Close of Nov 13, 2026
296.00 379.32
Market cap
EUR 2.94B
P/E
18.9x
P/B
2.42x
ROE
13.4%
Dividend yield
0.41%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is V16.F undervalued?

Graham number
Price351.00
Graham value246.38
Premium42.5%

V16.F trades 42.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Virbac SA fundamental analysis

No fundamental analysis for Virbac SA yet.

Virbac SA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Virbac SA

Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline chronic kidney disease; Prevexto that contains imidacloprid and flumethrin, providing long-lasting parasite protection collar for dogs and cats at risk of fleas, ticks, lice, and…

Full company profile